Cargando…
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial
AIMS: More than one-half of betel-quid (BQ) chewers have betel-quid use disorder (BUD). However, no medication has been approved. We performed a randomised clinical trial to test the efficacy of taking escitalopram and moclobemide antidepressants on betel-quid chewing cessation (BQ-CC) treatment. ME...
Autores principales: | Hung, Chung-Chieh, Lee, Chien-Hung, Ko, Albert Min-Shan, Lane, Hsien-Yuan, Lee, Chi-Pin, Ko, Ying-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216045/ https://www.ncbi.nlm.nih.gov/pubmed/32370818 http://dx.doi.org/10.1017/S2045796020000384 |
Ejemplares similares
-
Antidepressant-induced reduction in betel-quid use in patients with depression: A pioneer clinical study
por: Hung, Chung-Chieh, et al.
Publicado: (2020) -
Predictors of betel quid chewing behavior and cessation patterns in Taiwan aborigines
por: Lin, Chin-Feng, et al.
Publicado: (2006) -
The role of betel-quid chewing in smoking cessation among workers in Taiwan
por: Chen, Fu-Li, et al.
Publicado: (2014) -
Qualitative study for betel quid cessation among oral cancer patients
por: Lee, Chen-Yi, et al.
Publicado: (2018) -
Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers
por: Kaushal, Mishi, et al.
Publicado: (2012)